BRPI0905388A2 - "composição farmacêutica; compostos e métodos de tratamento de infecção por arenavirus" - Google Patents

"composição farmacêutica; compostos e métodos de tratamento de infecção por arenavirus"

Info

Publication number
BRPI0905388A2
BRPI0905388A2 BRPI0905388A BRPI0905388A BRPI0905388A2 BR PI0905388 A2 BRPI0905388 A2 BR PI0905388A2 BR PI0905388 A BRPI0905388 A BR PI0905388A BR PI0905388 A BRPI0905388 A BR PI0905388A BR PI0905388 A2 BRPI0905388 A2 BR PI0905388A2
Authority
BR
Brazil
Prior art keywords
compounds
methods
pharmaceutical composition
arenavirus infection
treating
Prior art date
Application number
BRPI0905388A
Other languages
English (en)
Inventor
Dennis E Hruby
Dongcheng Dai
Sean M Amberg
Tove C Bolken
Travis K Warren
Original Assignee
Siga Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siga Technologies Inc filed Critical Siga Technologies Inc
Publication of BRPI0905388A2 publication Critical patent/BRPI0905388A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0905388A 2008-01-15 2009-01-14 "composição farmacêutica; compostos e métodos de tratamento de infecção por arenavirus" BRPI0905388A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US645708P 2008-01-15 2008-01-15
PCT/US2009/030919 WO2009123776A2 (en) 2008-01-15 2009-01-14 Antiviral drugs for treatment of arenavirus infection

Publications (1)

Publication Number Publication Date
BRPI0905388A2 true BRPI0905388A2 (pt) 2015-10-13

Family

ID=41136068

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0905388A BRPI0905388A2 (pt) 2008-01-15 2009-01-14 "composição farmacêutica; compostos e métodos de tratamento de infecção por arenavirus"

Country Status (11)

Country Link
US (2) US8623347B2 (pt)
EP (1) EP2240023A4 (pt)
JP (1) JP5795714B2 (pt)
KR (1) KR20100113500A (pt)
CN (1) CN101990434B (pt)
AP (1) AP2010005308A0 (pt)
AU (1) AU2009232276B2 (pt)
BR (1) BRPI0905388A2 (pt)
CA (1) CA2712071A1 (pt)
WO (1) WO2009123776A2 (pt)
ZA (1) ZA201004193B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410149B2 (en) 2004-12-06 2013-04-02 Siga Technologies Inc. Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
US7994221B2 (en) 2004-12-06 2011-08-09 Siga Technologies, Inc. Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
WO2006062898A2 (en) 2004-12-06 2006-06-15 Siga Technologies, Inc. Compounds and methods for treating hemorrhagic fever viruses
WO2007120374A2 (en) 2006-02-01 2007-10-25 Siga Technologies, Inc. Anti-arenaviral compounds
US8791110B2 (en) 2006-02-01 2014-07-29 Siga Technologies, Inc. Anti-arenaviral compounds
US8871746B2 (en) 2006-03-02 2014-10-28 Kineta Four, LLC Antiviral drugs for treatment of arenavirus infection
JP5380078B2 (ja) 2006-03-02 2014-01-08 サイガ・テクノロジーズ・インコーポレーテッド アレナウイルス感染の治療のための抗ウイルス薬剤
US7977365B2 (en) 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
CN101743008A (zh) 2007-05-23 2010-06-16 西佳技术公司 用于治疗或预防登革热感染的抗病毒药
JP5393679B2 (ja) 2007-08-27 2014-01-22 シガ・テクノロジーズ・インコーポレーテッド アレナウイルス感染症を治療するための抗ウイルス薬
JP2015193572A (ja) * 2014-03-31 2015-11-05 宇部興産株式会社 パーフルオロアルキル基を含むビベンズイミダゾール化合物、およびその製造方法
WO2016004513A1 (en) * 2014-07-11 2016-01-14 Simon Fraser University Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methods
US9586949B2 (en) 2015-02-09 2017-03-07 Incyte Corporation Aza-heteroaryl compounds as PI3K-gamma inhibitors
EP4086259A1 (en) 2015-11-06 2022-11-09 Incyte Corporation Heterocyclic compounds as pi3k-gamma inhibitors
AR107293A1 (es) 2016-01-05 2018-04-18 Incyte Corp COMPUESTOS DE PIRIDINA Y PIRIDIMINA COMO INHIBIDORES DE PI3K-g
WO2017223414A1 (en) 2016-06-24 2017-12-28 Incyte Corporation HETEROCYCLIC COMPOUNDS AS PI3K-γ INHIBITORS
PT3697789T (pt) 2017-10-18 2021-12-31 Incyte Corp Derivados de imidazol condensados substituídos por grupos hidróxi terciários como inibidores de pi3kgama
HRP20240252T1 (hr) 2018-09-05 2024-05-24 Incyte Corporation Kristalni oblici inhibitora fosfoinozitid 3 kinaze (pi3k)
HUE066335T2 (hu) 2018-10-05 2024-07-28 Annapurna Bio Inc Vegyületek és készítmények APJ receptor aktivitáshoz kapcsolódó állapotok kezelésére

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104395D0 (en) * 1991-03-01 1991-04-17 Ici Plc Compound,preparation and use for metal extraction
US5877193A (en) * 1996-07-19 1999-03-02 Hoffmann-La Roche Inc. Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
EP1670804A2 (en) * 2003-09-10 2006-06-21 GPC Biotech AG Heterobicyclic compounds as pharmaceutically active agents
MX2007005348A (es) * 2004-11-03 2007-06-25 Teva Pharma Formas amorfas y polimorficas de sodio de telmisartan.
EP1945209B1 (en) 2005-08-12 2018-05-30 United States Government As Represented By The Secretary of The United States Army And The U.S. Army Medical Research & Materiel Command Broad spectrum antibacterial compounds
US7977365B2 (en) * 2006-03-02 2011-07-12 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
JP5380078B2 (ja) * 2006-03-02 2014-01-08 サイガ・テクノロジーズ・インコーポレーテッド アレナウイルス感染の治療のための抗ウイルス薬剤
GB0616359D0 (en) 2006-08-16 2006-09-27 Crysoptix Ltd Organic compound,optical film and method of production thereof

Also Published As

Publication number Publication date
WO2009123776A3 (en) 2009-12-30
ZA201004193B (en) 2011-04-28
JP2011519346A (ja) 2011-07-07
EP2240023A2 (en) 2010-10-20
US8623347B2 (en) 2014-01-07
CA2712071A1 (en) 2009-10-08
US20140100245A1 (en) 2014-04-10
AP2010005308A0 (en) 2010-06-30
US20110027227A1 (en) 2011-02-03
AU2009232276A1 (en) 2009-10-08
AU2009232276B2 (en) 2013-10-24
CN101990434A (zh) 2011-03-23
CN101990434B (zh) 2013-07-31
EP2240023A4 (en) 2010-12-29
WO2009123776A2 (en) 2009-10-08
KR20100113500A (ko) 2010-10-21
JP5795714B2 (ja) 2015-10-14

Similar Documents

Publication Publication Date Title
BRPI0905388A2 (pt) "composição farmacêutica; compostos e métodos de tratamento de infecção por arenavirus"
BR112012002628A2 (pt) "composição para tratamento de infecções por hbv"
BRPI0822625A2 (pt) "dispositivo espaçador modular para o tratamento de infecções por próteses"
BRPI0914902A2 (pt) composição farmacêutica e método para tratamento de mal de parkinson
BRPI0916125A2 (pt) "dispositivo de tratamento"
IL209380A0 (en) Small molecule inhibitors for the treatment or prevention of dengue virus infection
BRPI0810928A2 (pt) "composição farmacêutica"
BRPI0916049A2 (pt) "dispositivo para tratamento da cavidade dental e método para tratamento da cavidade dental"
BRPI0610514A2 (pt) composto, composição farmacêutica, e, método de tratamento de um distúrbio
BRPI0810354A2 (pt) Composto, uso de um composto, composição farmacêutica, e, método de tratamento de um dispositivo de dor
BRPI0813725A2 (pt) Métodos e composições para tratamento de doenças
HK1156038A1 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
BRPI0820568A2 (pt) Composto, composição farmacêutica, uso de um composto ou uma composição farmacêutica, e, método de tratamento de um humano ou animal
ITRE20060026A1 (it) Apparecchio per trattamenti medicinali
BRPI0908635A2 (pt) composto, composição farmacêutica e método de tratamento de câncer
ATE465229T1 (de) Textilbehandlungsverfahren und zusammensetzung
DE602006009764D1 (de) Terphenylderivate zur Alzheimerbehandlung
ITRE20060127A1 (it) Apparecchio per trattamenti medicali
AP2008004593A0 (en) Antivral drugs for treatment of arenavirus infection
GB0718446D0 (en) Compositions and methods for the treatment of infection
BRPI1007603A2 (pt) "composição de tratamento do cabelo"
BRPI0914371A2 (pt) "composto, composição farmacêutica, uso de um composto, método para tratar um indivíduo, e produto de combinação"
HK1131004A1 (en) Compounds for treating microbial infection and pharmaceutical use thereof
BRPI0607748A2 (pt) composto, composição farmacêutica, e, método de tratamento de um distúrbio
BRPI0814300A2 (pt) Composto, composição farmacêutica, e, método para tratar uma infecção viral

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: VIDE PARECER NO E-PARECER

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.